Abstract:Overdose of acetaminophen (APAP), the most widely used analgesic, results in acute liver failure. We have investigated the role of a post‐translational modification of proteins called O‐GlcNAcylation in pathogenesis of APAP‐induced liver injury, where a single β‐D‐N‐acetylglucosamine (O‐GlcNAc) moiety is added to proteins by an enzyme called O‐GlcNAc transferase (OGT) and removed by an enzyme called O‐GlcNAcase (OGA). Male C57BL/6J mice were treated with 300 mg/kg APAP followed by Thiamet‐G (TMG, 400 mg/kg) a specific inhibitor of OGA that induces O‐GlcNAcylation, 1.5 hr after APAP administration. Progression of liver injury was studied over a time course of 0 to 24 hr. TMG treatment resulted in significant increase in hepatic O‐GlcNAc. The mice treated with 400 mg/kg TMG exhibited significantly higher APAP‐induced liver injury as indicated by increase in serum transaminase levels and histopathological analysis, as well as a prolonged JNK activation. Treatment with TMG did not affect hepatic CYP2E1 levels, APAP protein adduct formation, APAP induced mitochondrial damage, hepatic glutathione (GSH), or depletion of GSH after APAP treatment. C57BL/6J mice were also treated with 50 mg/kg TMG every other day for 15 days followed by 300 mg/kg APAP and sacrificed at 24 hr. Mice treated with 50 mg/kg TMG showed a similar increase in APAP‐induced liver injury. Next we used hepatocyte specific OGT knockout mice (OGT KO), which have decreased O‐GlcNAcylation to study APAP toxicity. OGT KO and WT control mice were treated with 300 mg/kg and sacrificed on a timecourse from 0–24 hr. OGT KO mice showed dramatic decrease in liver injury as compared to WT mice. APAP protein adducts was significantly decreased in OGT KO mice when compared to WT control mice. There was no difference CYP2E1 activity showing that OGT KO did not alter cytochrome P450 levels and alter APAP metabolism. Hepatic GSH depletion was equal in OGT KO and WT mice but GSH was rapidly replenished by 6hr after APAP treatment in OGT KO mice, while WT mice did not fully replenish until 24hr post APAP. Taken together, these data indicate that induction in cellular O‐GlcNAcylation exacerbates and decrease in O‐GlcNAcylation protects from APAP induced liver injury. These studies have identified a novel mechanism of pathogenesis of acute liver injury induced by APAP and highlighted a novel therapeutic target for acute liver failure. Support or Funding Information R01DK098414

In vivo upstream factors of mouse hepatotoxic mechanism with sustained hepatic glutathione depletion: Acetaminophen metabolite-erythrocyte adducts and splenic macrophage-generated reactive oxygen species

Single-cell RNA Sequencing Reveals the Dynamics of Hepatic Non-Parenchymal Cells in Autoprotection Against Acetaminophen-Induced Hepatotoxicity

Inhibiting Hepatocyte Uric Acid Synthesis and Reabsorption Ameliorates Acetaminophen-Induced Acute Liver Injury in Mice.

Both TREM2-dependent macrophages and Kupffer cells play a protective role in APAP-induced acute liver injury

Glutaredoxin-1 Alleviates Acetaminophen-Induced Liver Injury by Decreasing Its Toxic Metabolites

Acetaminophen-induced hepatotoxicity predominantly via inhibiting Nrf2 antioxidative pathway and activating TLR4-NF-κB-MAPK inflammatory response in mice

Deletion of Glyoxalase 1 Exacerbates Acetaminophen-Induced Hepatotoxicity in Mice

Therapeutic Role of Inducible Nitric Oxide Synthase Expressing Myeloid-Derived Suppressor Cells in Acetaminophen-Induced Murine Liver Failure

Acetaminophen-induced Cytotoxicity on Human Normal Liver L-02 Cells and the Protection of Antioxidants.

P-Aminophenol-Induced Liver Toxicity: Tentative Evidence of A Role for Acetaminophen

Iron loading exerts synergistic action via a different mechanistic pathway from that of acetaminophen-induced hepatic injury in mice

Deciphering Acetaminophen-Induced Hepatotoxicity: The Crucial Role of Transcription Factors like Nuclear Factor Erythroid 2-Related Factor 2 as Genetic Determinants of Susceptibility to Drug-Induced Liver Injury

CD36 deficiency ameliorates drug-induced acute liver injury in mice

Removal of Acetaminophen Protein Adducts by Autophagy Protects Against Acetaminophen-Induced Liver Injury in Mice.

CXCL16 deficiency attenuates acetaminophen-induced hepatotoxicity through decreasing hepatic oxidative stress and inflammation in mice

Acetaminophen-Induced Rat Hepatotoxicity Based on M1/M2-Macrophage Polarization, in Possible Relation to Damage-Associated Molecular Patterns and Autophagy

Allyl Methyl Trisulfide Protected Against Acetaminophen (Paracetamol)-Induced Hepatotoxicity by Suppressing CYP2E1 and Activating Nrf2 in Mouse Liver.

Role of Hepatic O‐GlcNAcylation on Acetaminophen‐Induced Liver Injury

Integrative Proteomics and Immunochemistry Analysis of the Factors in the Necrosis and Repair in Acetaminophen-Induced Acute Liver Injury in Mice.

Activation of P62-Keap1-nrf2 Antioxidant Pathway in the Early Stage of Acetaminophen-Induced Acute Liver Injury in Mice

Comparative metabonomic analysis of hepatotoxicity induced by acetaminophen and its less toxic meta-isomer